Company intelligence / Profile preview

Bioemmei s.r.l.

Ownership: Private
Development stage: Commercial

Overview

Bioemmei s.r.l. develops and markets oral hygiene products such as Gelio3, which is indicated for gum protection, mucosal repair after dental procedures, relief for children’s gums, dermatitis treatment, and as a hand sanitiser. The company provides both preventive and restorative solutions for oral health.

Therapeutic areas: OtherDermatology
Modalities: Oral care gelsMucosal reparative treatmentsSanitizing products
Industry: Consumable Medical Devices

Drug pipeline

1 asset

Gelio3

Commercial

Indications: Periodontal disease, Oral infections, Dental hygiene

Beyond the preview

Go deeper on Bioemmei s.r.l..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bioemmei s.r.l..

Explore the full profile